Cannabis and Cannabinoid Research (CCR) is honored to announce that the Society of Cannabis Clinicians (SCC) has named CCR its Official Journal. The SCC is a nonprofit educational and scientific society of physicians and health care professionals dedicated to the education and research support of cannabis for medical use. Its mission is to unite members of the various medical specialties and allied professionals with this common purpose. This collaboration between the SCC and Cannabis and Cannabinoid Research is one that will greatly contribute to advance the understanding of the medical use of cannabis and benefit a whole community of medical specialists and allied professionals.
“The SCC is proud to announce our official partnership with the Cannabis and Cannabinoids Research Journal! Every member will now be given access to the journal as a part of paid membership benefits. We are thrilled to continue to expand our mission of cannabis scientific education to the membership with this new partnership. For those who are interested in getting a free print copy of the most recent journal publication, they will be distributed at the October 5th conference in Los Angeles. We will continue to work together to bring more clinical science and research in the field of cannabis,” says Sherry Yafai, MD, Co-Vice President of the SCC.
“Changes in the legal landscape are generating new interest in cannabis as a medicine and are posing important scientific and educational challenges,” says Daniele Piomelli, PhD, Editor-in-Chief of CCR. “Cannabis and Cannabinoid Research is delighted to partner with the Society of Cannabis Clinicians to promote rigorous clinical research on cannabis and to help spread new discoveries to practicing physicians as well as to the scientific community.”
Dr. Piomelli and the leadership of Cannabis and Cannabinoid Research look forward to working with the SCC to enhance its mission, the Journal, and the field.
Cannabis and Cannabinoid Research is also the official journal of the International Cannabinoid Research Society (ICRS), and works in collaboration with the International Association for Cannabinoid Medicines (IACM) and Fundación CANNA.
About the Journal
Cannabis and Cannabinoid Research is the premier journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Cannabis and Cannabinoid Research is indexed in leading databases such as PubMed Central, EMBASE/Excerpta Medica, Scopus, and ProQuest.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Palliative Medicine and Cancer Biotherapy and Radiopharmaceuticals. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.